HTC
IPSC icon

Hershey Trust Company’s Century Therapeutics IPSC Stock Holding History

Hershey Trust Company’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,723
Closed -$40K – 24
2022
Q2 		$40K Hold
4,723
– – ﹤0.01% 32
2022
Q1 		$59K Hold
4,723
– – ﹤0.01% 30
2021
Q4 		$75K Buy
+4,723
New +$88.7K ﹤0.01% 37

Other funds holding IPSC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Hershey Trust Company's IPSC Position: Q3 2022 in Review

Hershey Trust Company sold out of Century Therapeutics (IPSC) in Q3 2022, closing a stake of 4,723 shares — an estimated $40K sold.

Hershey Trust Company first reported a position in IPSC in Q4 2021 and held it in 3 quarters. The position peaked at $75K in Q4 2021. 54 funds tracked by Wall St. Rank hold IPSC as of Q3 2022.

  • Hershey Trust Company reported no remaining Century Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Hershey Trust Company sold 4,723 Century Therapeutics shares in Q3 2022, an estimated $40K.
  • Hershey Trust Company first reported a position in Century Therapeutics in Q4 2021 and held it in 3 quarters.
  • Hershey Trust Company's Century Therapeutics position peaked at $75K in Q4 2021.
  • 54 funds tracked by Wall St. Rank held Century Therapeutics as of Q3 2022.

Based on Hershey Trust Company's 13F filing for Q3 2022, filed 15 Nov 2022.